1 Min Read
April 7 (Reuters) - Cadila Healthcare Ltd
* Cadila’s topical manufacturing facility successfully completes USFDA inspection
* Says no observation (483) was issued Source text: (bit.ly/2oQ2bYt) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.